Printer Friendly

CHEMDESIGN NAMES MICHAEL J. O'DONNELL AS VICE PRESIDENT AND CHIEF FINANCIAL OFFICER

 CHEMDESIGN NAMES MICHAEL J. O'DONNELL
 AS VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
 FITCHBURG, Mass., April 6 /PRNewswire/ -- ChemDesign Corporation (NASDAQ: CDCC) today announced that Michael J. O'Donnell has joined ChemDesign as vice president and chief financial officer.
 O'Donnell was previously vice president, chief financial officer and a director of Aritech Corp. Aritech is publicly traded and is a leading manufacturer and distributor of products for the worldwide security equipment market. O'Donnell joined Aritech in 1980 when it was a division of ADT and held several positions in both finance and operations.
 O'Donnell is a certified public accountant and received his B.S. in Accounting and M.S. in Finance from Bentley College. His prior professional affiliations included Peat, Marwick, Mitchell & Company and Middlesex Insurance Company.
 ChemDesign is engaged primarily in the development, manufacture and sale of fine chemicals on a custom basis. As a custom fine chemical producer, the company provides manufacturing services to its customers and produces a wide variety of products, each manufactured to the customer's specifications. The company also manufactures and sells other fine and specialty chemicals.
 -0- 4/6/92
 /CONTACT: Steve E. Borgeson of ChemDesign, 508-345-9999/
 (CDCC) CO: ChemDesign Corporation ST: Massachusetts IN: CHM SU: PER


EG -- NE012 -- 5437 04/06/92 14:41 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 6, 1992
Words:210
Previous Article:DELMARVA POWER SELECTS DCEP, NATIONAL ENERGY RESOURCE; TWO PROJECTS TO SUPPLY 198 MW BY MID-1990s
Next Article:CARTER-WALLACE ANNOUNCES LICENSING AGREEMENT WITH SCHERING-PLOUGH FOR ITS ANTI-EPILEPTIC DRUG FELBAMATE


Related Articles
CHEMDESIGN RESPONDS TO RECENT MARKET ACTIVITY
CHEMDESIGN REPORTS SECOND QUARTER RESULTS
CHEMDESIGN ACCEPTS LARGE ORDER FOR FINE CHEMICAL INTERMEDIATE FROM NEW DOMESTIC CUSTOMER
CHEMDESIGN RESPONDS TO RECENT ACTIVITY IN ITS STOCK
CHEMDESIGN REPORTS RECORD FOURTH QUARTER SALES AND IMPROVED FOURTH QUARTER EARNINGS
CHEMDESIGN'S RECOVERY CONTINUES THROUGH FIRST QUARTER OF 1993
CHEMDESIGN REPORTS SECOND QUARTER RESULTS
CHEMDESIGN ELECTS NEW DIRECTOR
CHEMDESIGN REPORTS FOURTH QUARTER AND YEAR END SALES AND EARNINGS
CHEMDESIGN CORPORATION ANNOUNCES END OF ANTITRUST WAITING PERIOD FOR PROPOSED MERGER OF CHEMDESIGN CORPORATION AND MILES INC. SUBSIDIARY

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters